Jobs / United States / Regeneron Pharmaceuticals INC
Associate Director, Precision Medicine (Cell Medicine)
Regeneron Pharmaceuticals INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles13 certified filings for “Associate Director Imaging” (Natural Sciences Managers) in NY: $201k–$281k, median $225k. Most were filed at wage level II (69%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 2 days agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build Our Future Together We are seeking to hire a Precision Medicine Scientific Lead to oversee the development and execution of biomarker strategies for novel cell therapies, cell transfer conditioning agents and combinations with bispecific antibodies across multiple disease areas (Oncology and Immunology). In this highly matrixed role, they will design, develop, communicate across levels and operationally implement clinical biomarker strategies to support selecet programs in early and late stage drug development. Clinical biomarker assays include pharmacokinetic assays, mechanism of action, patient stratification assays and pharmacodynamic assays. The candidate will collaborate with teams internal to RCM and more broadly Regeneron or with contract research organizations to develop and implement clinical biomarker assays. When & where: • Work Location: Cambridge, MA or Tarrytown, NY • Hybrid: 4 days per week on site Discover your role: • Program-level Precision Medicine lead that develops and implements the strategic vision for pharmacokinetic, pharmacodynamic, and exploratory biomarkers for clinical studies enabling indication and/or patient selection, early indication of biological activity, and to identify potential novel combinations. • String collaboration with Biomarker and clinical operation teams to implement specific biomarker and exploratory sample collection and analyses in all relevant clinical studies in selected programs • Key individual contributor and precision medicine representative to development and Cell therapy characterization teams with a remit to integrate, influence and deliver biomarker strategies from initial concept to execution, data delivery and results interpretation. • Collaborate with internal Regeneron laboratories and groups (e.g. BioAnalytical, Clinical Pharmacology, Molecular Profiling, CDX, Discovery Research, Analytical Innovations, DMSQ etc.) to develop plan for validation and application of assays in the clinic. • Accountability for ensuring complex clinical assays used in programs are fit-for-purpose (whether developed and validated internally or externally) • Collaborate with Discovery Research and product development teams to facilitate appropriate incorporation of Precision Medicine biomarker strategies for molecules in discovery phases (leading to candidate molecule selection) through to the clinic. • Represent Regeneron externally thorough collaborations and/or presentations. • Contribute to Clinical Protocol, schedule of Assessments, clinical study reports, technical reports, data agreements, scientific publications and make recommendations to development teams and management This role requires: • PhD and 8+ years of experience participating effectively on cross-disciplinary teams in pharmaceutical or biotech industry. • Experience in clinical assay development, validation and implementation with strong experience in Immunology is preferred. • The ability to drive, manage, complete and deliver results for complex multi-functional projects • Excellent communication and presentation skills and high emotional intelligence, organizational skills and effective team skills Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Travele